An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Description
The development of effective SARS-CoV-2 vaccines has been essential to control COVID-19, but significant challenges remain. One problem is intramuscular administration, which does not induce robust mucosal immune responses in the upper airways-the
